ASP Isotopes Inc.
ASPI Nasdaq· Miscellaneous Chemical Products
Last close · Oct 23, 2026
$1.95
KIRA · Stoqly’s AI analyst, in plain words
- ASP Isotopes Inc. had $23.8M of revenue in fiscal 2025, up 475.5% on the year before.
- Its operating margin was −251.2%, up 384.8 pts: of every 100 in sales, about −251 is left after running the business.
- ASP Isotopes Inc. lost $160M in fiscal 2025.
- Free cash flow was −$47.4M in fiscal 2025, −198.9% of revenue.
- ASP Isotopes Inc. returned $0.0M to shareholders in fiscal 2025. The diluted share count rose 49.1%.
- ASP Isotopes Inc. has $325M more cash than debt.
Market cap
$239M
P/E
—
Revenue
$23.8M
Net income
−$160M
Free cash flow
−$47.4M
Operating margin
−251.2%
ASP Isotopes Inc. in 30 seconds · fiscal 2025
Are sales growing?
+475.5%
Yes. Sales grew 475.5% last year.
Does it make a profit?
−670.2%
No. It lost money last year.
Does profit turn into cash?
−198.9%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What ASP Isotopes Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Apr 10, 2026
- Legal name
- ASP Isotopes Inc.
- CIK
- 0001921865
ASP Isotopes Inc. · ASPI
Results and finances
The last 4 fiscal years. Amounts in USD.
| Fiscal year | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Sales and profit | ||||
| Revenue | $0.0M | $0.4M | $4.1M | $23.8M |
| Revenue growth | — | — | 857.0% | 475.5% |
| Net interest income | $0.0M | — | — | — |
| Gross margin | — | 32.1% | 38.6% | 14.3% |
| Operating margin | — | −3,704.8% | −636.0% | −251.2% |
| Net income | −$4.9M | −$16.3M | −$32.4M | −$160M |
| Net margin | — | −3,763.1% | −782.4% | −670.2% |
| Diluted EPS | — | −$0.49 | −$0.63 | −$2.11 |
| Cash | ||||
| Cash from operations | −$2.9M | −$5.4M | −$16.7M | −$37.8M |
| Capital expenditure | $4.5M | $2.3M | $9.7M | $9.7M |
| Free cash flow | −$7.4M | −$7.7M | −$26.4M | −$47.4M |
| FCF margin | — | −1,788.4% | −636.4% | −198.9% |
| Dividends paid | — | $0.0M | $2.8M | $0.0M |
| Share count change | — | — | 68.4% | 49.1% |
| Debt and strength | ||||
| Cash and short-term investments | $2.4M | $7.9M | $61.9M | $327M |
| Debt incl. finance leases | — | — | $2.4M | $2.1M |
| Shareholders' equity | $9.8M | $16.3M | $47.9M | $204M |
| Current ratio | 1.7x | 1.9x | 9.3x | 12.2x |
| Interest coverage | — | −135.4x | −101.8x | −104.2x |
| Returns and quality | ||||
| Return on equity | −50.4% | −124.8% | −101.0% | −126.8% |
| Return on tangible equity | −50.4% | −125.1% | −72.5% | −80.6% |
| Piotroski F-score | — | — | 5 | 5 |
| Altman Z'' | −0.1 | −3.6 | 1.4 | 3.4 |
Insiders bought, 12 months
$0.1M
1 insider
Insiders sold, 12 months
$9.5M
7 insiders
Of sales under plans
79%
$7.5M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
ASP Isotopes Inc. · ASPI
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $1.95 a share, the company is worth $239M.
Source: SEC EDGAR XBRL filings (CIK 0001921865). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.